Scientists have unveiled the first and largest encyclopaedia of protein alterations in soft tissue sarcomas – opening the door to a new era of understanding and treatment for this group of rare cancers. The pioneering encyclopaedia, or ‘Rosetta Stone’, of sarcoma biology compiles a wealth of… Read More
Scientists in Japan have used a novel technique to identify a protein complex degraded by autophagy that has a possible role in liver cancer. Biomolecular condensates like p62 body have a role in cleansing cellular waste through ‘autophagy’, though much remains unknown about the constituents of… Read More
Proteomics company SomaLogic is sponsoring the Genomax Research Grant Award for researchers in Singapore, the company’s first grant in the APAC region. The winners of the award will receive proteomic data from SomaLogic’s 7,000-plex assay, which will be run at Singapore-based Molecular Genomics. The… Read More
Today marks the start of SLAS2023 in San Diego. Over the last week, DDW’s Megan Thomas has narrated five articles from the SLAS2023 supplement as part of the DDW Events podcast series. Episodes include: A Welcome to SLAS 2023 Acquiring deeper insights and acceleration with AI Connecting… Read More
Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is episode four, How machine learning and lab automation are changing the… Read More
Bertis, a South Korean proteomics-based precision medicine technology company, has established a US-based wholly-owned entity to expand its global presence. The subsidiary, called Bertis Bioscience, aims to establish a San Diego-based CLIA-certified lab facility in early Q4, 2022. It will offer proteomics-based screening and diagnostic tests, as well as an… Read More
Alamar Biosciences, a proteomics platform, and Abcam, innovators in life sciences research tools, have partnered to further their understanding of the human proteome. Proteomics The field of proteomic analysis is in the spotlight. Its advance not only enhances the understanding of fundamental biology, but also… Read More
Many small molecule inhibitors have been approved as cancer therapeutics, but they can confer mutation-based drug resistance and many potential cancer targets remain ‘undruggable’. One emerging cancer therapeutic strategy that shows promise for drug development is the use of targeted protein degradation (TPD). This approach has many advantages,… Read More
This On Demand webinar by Olink features Bill Hunt, Director of Product Management at Fluidigm, and Dr Jenny Rubin, Development Engineer at Olink Proteomics. The webinar examines the new Olink Signature Q100, a benchtop system for protein biomarker analysis. Hunt discusses “Signature Q100 System – Evolution of workhorse for protein expression”, while Rubin… Read More
Bruker has launched new products, as outlined June 1-3, 2021 at the eXceed Symposia 2021. The products include timsTOF trueSCP and timsTOF Pro 2. Mass spectrometric proteomics has become a staple of modern research in understanding biological function and disease mechanisms. Healthy or diseased tissues that seem homogenous are composed… Read More
Olink has created a whitepaper which pulls together three recently published research studies highlighting the importance of linking genetic and protein expression data in the context of disease phenotypes in order to identify new, robust drug targets. According to Olink, while many drugs are developed based on genomic findings, it’s… Read More
Lu Rahman looks at the rise of proteomics, its growing role in the quest for new treatments and some of the work being carried out in this field. Due to the introduction of technology-enabled proteomics products, the global proteomics market is expected to reach $24.8 billion by 2024, says Grand View… Read More
